Home > Cardiology > Fewer than half of stroke patients receive indicated dual-antiplatelet therapy

Fewer than half of stroke patients receive indicated dual-antiplatelet therapy


Notice: Undefined index: new_doi_fields in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/functions.php on line 138

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/functions.php on line 138

Notice: Undefined index: new_doi_fields in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/functions.php on line 174

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/functions.php on line 174

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/functions.php on line 175
Journal
JAMA Internal Medicine
Reuters Health - 30/03/2022 - Fewer than half of ischemic stroke patients whom guidelines say should get dual-antiplatelet therapy (DAPT) actually receive the treatment, a new study suggests.  Analysis of data from more than a million ischemic-stroke patients in the U.S. revealed that after the American Heart Association and American Stroke Association released their updated guidelines in 2019, 54.5% of stroke patients received monotherapy upon hospital discharge and 44.9% received DAPT, researchers report in JAMA Internal Medicine.  "Although recommendations for appropriate DAPT exist, it appears that they are not closely followed in U.S. clinical practice," s...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on